GlassScriptPhysician profile
Delu Zhou
NPI 1114216413
$1,105.53
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $37.99 · 2021: $151 · 2022: $64.63 · 2023: $158 · 2024: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $195.19 | 2019-2024 | Keytruda, Welireg, Lynparza |
| Foundation Medicine, INC. | $192.62 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $144.58 | 2019-2024 | |
| Lilly USA, LLC | $123.67 | 2019-2024 | Verzenio, Cyramza, Jaypirca |
| Eisai INC. | $70.83 | 2023-2024 | |
| Springworks Therapeutics, INC. | $68.67 | 2024 | Ogsiveo |
| Adaptive Biotechnologies Corporation | $56.56 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.93 | 2024 | Fruzaqla |
| Daiichi Sankyo INC. | $30.06 | 2022 | |
| Pfizer INC. | $29.62 | 2024 | |
| Seagen INC. | $25.34 | 2023 | Padcev |
| Blueprint Medicines Corporation | $22.35 | 2024 | |
| Astellas Pharma US INC | $20.33 | 2023 | Xtandi |
| Cepheid | $18.86 | 2021 | |
| Abbott Laboratories | $18.01 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho-Clinical Diagnostics, INC. | $16.01 | 2021 | |
| Medline Industries LP | $15.61 | 2024 | Medline Industries, INC. |
| Cumberland Pharmaceuticals, INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delu Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.